Drugs / Venus
last change Mar 2024 re-read 2 minutes ago

Venus

Developed for
vulvovaginal candidiasis
Investigated by
EMS

Trials 1 · a red edge is where a trial was stopped

2023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT05031481 Jul 2022 → Dec 2023 vulvovaginal candidiasis EMS Withdrawn No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Venus ClinicalTrials.gov intervention name — accepted as the source's own label NCT05031481
Route Other “Venus vaginal cream 20 + 0,064, single-dose.” NCT05031481